Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription

Articles published in Cancer Res

Retrieve available abstracts of 111 articles:
HTML format

Single Articles

    June 2021
  1. SHRIKI A, Lanton T, Sonnenblick A, Levkovitch-Siany O, et al
    Multiple Roles of IL-6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis.
    Cancer Res. 2021 Jun 11. pii: 0008-5472.CAN-21-0321.
    PubMed     Abstract available

    May 2021
  2. ZHAO Z, Gad H, Benitez-Buelga C, Sanjiv K, et al
    NEIL3 prevents senescence in hepatocellular carcinoma by repairing oxidative lesions at telomeres during mitosis.
    Cancer Res. 2021 May 27. pii: 0008-5472.CAN-20-1028.
    PubMed     Abstract available

  3. MA APY, Yeung CLS, Tey SK, Mao X, et al
    Suppression of ACADM-mediated fatty acid oxidation promotes hepatocellular carcinoma via aberrant Cav1/SREBP-1 signaling.
    Cancer Res. 2021 May 11. pii: 0008-5472.CAN-20-3944.
    PubMed     Abstract available

    April 2021
  4. LEUNG HW, Leung CO, Lau EY, Chung KPS, et al
    EPHB2 activates beta-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma.
    Cancer Res. 2021 Apr 26. pii: 0008-5472.CAN-21-0184.
    PubMed     Abstract available

  5. DU L, Li Y, Kang M, Feng M, et al
    USP48 is upregulated by Mettl14 to attenuate hepatocellular carcinoma via regulating SIRT6 stabilization.
    Cancer Res. 2021 Apr 26. pii: 0008-5472.CAN-20-4163.
    PubMed     Abstract available

  6. RICCIOTTI E, Wangensteen KJ, FitzGerald GA
    Aspirin in hepatocellular carcinoma.
    Cancer Res. 2021 Apr 23. pii: 0008-5472.CAN-21-0758.
    PubMed     Abstract available

    March 2021
  7. ZHANG C, Gao Y, Du C, Markowitz GJ, et al
    Hepatitis B-induced IL-8 Promotes Hepatocellular Carcinoma Venous Metastasis and Intrahepatic Treg Accumulation.
    Cancer Res. 2021 Mar 2. pii: 0008-5472.CAN-20-3453.
    PubMed     Abstract available

    February 2021
  8. MENG Y, Zhao Q, An L, Jiao S, et al
    A TNFR2-hnRNPK axis promotes primary liver cancer development via activation of YAP signaling in hepatic progenitor cells.
    Cancer Res. 2021 Feb 22. pii: 0008-5472.CAN-20-3175.
    PubMed     Abstract available

  9. BI L, Ren Y, Feng M, Meng P, et al
    HDAC11 regulates glycolysis through the LKB1/AMPK signaling pathway to maintain hepatocellular carcinoma stemness.
    Cancer Res. 2021 Feb 18. pii: 0008-5472.CAN-20-3044.
    PubMed     Abstract available

    January 2021
  10. YAMADA K, Oikawa T, Kizawa R, Motohashi S, et al
    Unconventional Secretion of PKCdelta Exerts Tumorigenic Function via Stimulation of ERK1/2 Signaling in Liver Cancer.
    Cancer Res. 2021;81:414-425.
    PubMed     Abstract available

  11. HONG SH, Son KH, Ha SY, Wee TI, et al
    Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer.
    Cancer Res. 2021;81:356-370.
    PubMed     Abstract available

  12. GENG Y, Fan J, Chen L, Zhang C, et al
    A Notch-Dependent Inflammatory Feedback Circuit between Macrophages and Cancer Cells Regulates Pancreatic Cancer Metastasis.
    Cancer Res. 2021;81:64-76.
    PubMed     Abstract available

  13. BATTISTELLI C, Garbo S, Riccioni V, Montaldo C, et al
    Design and Functional Validation of a Mutant Variant of the LncRNA HOTAIR to Counteract Snail Function in Epithelial-to-Mesenchymal Transition.
    Cancer Res. 2021;81:103-113.
    PubMed     Abstract available

    December 2020
  14. CAI LY, Chen SJ, Xiao SH, Sun QJ, et al
    Targeting p300/CBP attenuates hepatocellular carcinoma progression through epigenetic regulation of metabolism.
    Cancer Res. 2020 Dec 23. pii: 0008-5472.CAN-20-1323.
    PubMed     Abstract available

  15. ZHOU Q, Tian W, Jiang Z, Huang T, et al
    A positive feedback loop of AKR1C3-mediated activation of NF-kappaB and STAT3 facilitates proliferation and metastasis in hepatocellular carcinoma.
    Cancer Res. 2020 Dec 23. pii: 0008-5472.CAN-20-2480.
    PubMed     Abstract available

  16. FEI F, Sun S, Li Q, Pei Z, et al
    Combinatorial normalization of liver-derived cytokine pathways alleviates hepatic tumor-associated cachexia in zebrafish.
    Cancer Res. 2020 Dec 21. pii: 0008-5472.CAN-20-2818.
    PubMed     Abstract available

  17. THOMANN S, Weiler SME, Marquard S, Rose F, et al
    YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis.
    Cancer Res. 2020;80:5502-5514.
    PubMed     Abstract available

    October 2020
  18. WILLS CA, Liu X, Chen L, Zhao Y, et al
    Chemotherapy-Induced Upregulation of Small Extracellular Vesicle-Associated PTX3 Accelerates Breast Cancer Metastasis.
    Cancer Res. 2020 Oct 28. pii: 0008-5472.CAN-20-1976.
    PubMed     Abstract available

  19. MATSUMORI T, Kodama Y, Takai A, Shiokawa M, et al
    Hes1 is essential in proliferating ductal cell-mediated development of intrahepatic cholangiocarcinoma.
    Cancer Res. 2020 Oct 16. pii: 0008-5472.CAN-20-1161.
    PubMed     Abstract available

  20. MORITA T, Kodama Y, Shiokawa M, Kuriyama K, et al
    CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma.
    Cancer Res. 2020;80:4058-4070.
    PubMed     Abstract available

    August 2020
  21. UROSEVIC J, Blasco MT, Llorente A, Bellmunt A, et al
    ERK1/2 signaling induces upregulation of ANGPT2 and CXCR4 to mediate liver metastasis in colon cancer.
    Cancer Res. 2020 Aug 19. pii: 0008-5472.CAN-19-4028.
    PubMed     Abstract available

  22. LUO C, Liang J, Sharabi K, Hatting M, et al
    Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency.
    Cancer Res. 2020;80:3215-3221.
    PubMed     Abstract available

  23. ZHANG Y, Cedervall J, Hamidi A, Herre M, et al
    Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis.
    Cancer Res. 2020;80:3345-3358.
    PubMed     Abstract available

    July 2020
  24. MIDORIKAWA Y, Yamamoto S, Tatsuno K, Renard-Guillet C, et al
    Accumulation of molecular aberrations distinctive to hepatocellular carcinoma progression.
    Cancer Res. 2020 Jul 8. pii: 0008-5472.CAN-20-0225.
    PubMed     Abstract available

    June 2020
  25. YANG F, Wei Y, Han D, Li Y, et al
    Interaction with CD68 and regulation of GAS6 expression by endosialin in fibroblasts drives recruitment and polarization of macrophages in hepatocellular carcinoma.
    Cancer Res. 2020 Jun 26. pii: 0008-5472.CAN-19-2691.
    PubMed     Abstract available

    May 2020
  26. CHEN J, Mitra A, Li S, Song S, et al
    Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFbeta Signaling.
    Cancer Res. 2020;80:1819-1832.
    PubMed     Abstract available

    April 2020
  27. ZHANG L, Huo Q, Ge C, Zhao F, et al
    ZNF143-mediated H3K9 trimethylation upregulates CDC6 by activating MDIG in hepatocellular carcinoma.
    Cancer Res. 2020 Apr 20. pii: 0008-5472.CAN-19-3226.
    PubMed     Abstract available

    March 2020
  28. ZHU H, Yan F, Yuan T, Qian M, et al
    USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.
    Cancer Res. 2020 Mar 26. pii: 0008-5472.CAN-19-2388.
    PubMed     Abstract available

  29. TAN S, Xu Y, Wang Z, Wang T, et al
    Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling.
    Cancer Res. 2020;80:1130-1142.
    PubMed     Abstract available

    February 2020
  30. SCHULIEN I, Hockenjos B, van Marck V, Ayata CK, et al
    Extracellular ATP and Purinergic P2Y2 Receptor Signaling Promote Liver Tumorigenesis in Mice by Exacerbating DNA Damage.
    Cancer Res. 2020;80:699-708.
    PubMed     Abstract available

  31. HEBERT JD, Myers SA, Naba A, Abbruzzese G, et al
    Proteomic profiling of the ECM of xenograft breast cancer metastases in different organs reveals distinct metastatic niches.
    Cancer Res. 2020 Feb 4. pii: 0008-5472.CAN-19-2961.
    PubMed     Abstract available

  32. GRAMANTIERI L, Pollutri D, Gagliardi M, Giovannini C, et al
    MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma.
    Cancer Res. 2020 Feb 3. pii: 0008-5472.CAN-19-0472.
    PubMed     Abstract available

  33. LIANG J, Zhao H, Diplas BH, Liu S, et al
    Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition.
    Cancer Res. 2020;80:510-523.
    PubMed     Abstract available

    January 2020
  34. LIAO K, Deng S, Xu L, Pan W, et al
    A Feedback Circuitry between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis.
    Cancer Res. 2020 Jan 16. pii: 0008-5472.CAN-19-2060.
    PubMed     Abstract available

    December 2019
  35. WU Y, Zhao YM, Huan L, Zhao J, et al
    A LTR retrotransposon-derived long non-coding RNA lncMER52A promotes hepatocellular carcinoma progression by binding p120-catenin.
    Cancer Res. 2019 Dec 24. pii: 0008-5472.CAN-19-2115.
    PubMed     Abstract available

    November 2019
  36. MATTHEW-ONABANJO AN, Janusis J, Mercado-Matos J, Carlisle AE, et al
    Beclin 1 promotes endosome recruitment of hepatocyte growth factor tyrosine kinase substrate (HRS) to suppress tumor proliferation.
    Cancer Res. 2019 Nov 19. pii: 0008-5472.CAN-19-1555.
    PubMed     Abstract available

  37. YARCHOAN M, Agarwal P, Villanueva A, Rao S, et al
    Correction: Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.
    Cancer Res. 2019;79:5897.

  38. DAUKI AM, Blachly JS, Kautto EA, Ezzat S, et al
    Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma Progression.
    Cancer Res. 2019 Nov 4. pii: 0008-5472.CAN-19-1117.
    PubMed     Abstract available

  39. ZHOU J, Liu Y, Zhang Y, Li Q, et al
    Modeling tumor evolutionary dynamics to predict clinical outcomes for patients with metastatic colorectal cancer: a retrospective analysis.
    Cancer Res. 2019 Nov 1. pii: 0008-5472.CAN-19-1940.
    PubMed     Abstract available

    October 2019
  40. FEKRY B, Ribas Latre A, Baumgartner C, Mohamed AMT, et al
    HNF4alpha-deficient Fatty Liver Provides a Permissive Environment for Sex-independent Hepatocellular Carcinoma.
    Cancer Res. 2019 Oct 1. pii: 0008-5472.CAN-19-1277.
    PubMed     Abstract available

    September 2019
  41. JEE BA, Choi JH, Rhee H, Yoon S, et al
    Dynamics of genomic, epigenomic, and transcriptomic aberrations during stepwise hepatocarcinogenesis.
    Cancer Res. 2019 Sep 10. pii: 0008-5472.CAN-19-0991.
    PubMed     Abstract available

  42. YARCHOAN M, Agarwal P, Villanueva A, Rao S, et al
    Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.
    Cancer Res. 2019;79:4326-4330.
    PubMed     Abstract available

    August 2019
  43. XU M, Wang J, Xu Z, Li R, et al
    SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model.
    Cancer Res. 2019 Aug 5. pii: 0008-5472.CAN-18-3750.
    PubMed     Abstract available

    July 2019
  44. LIM LJ, Wong SYS, Huang F, Lim S, et al
    Roles and Regulation of Long non-coding RNAs in Hepatocellular Carcinoma.
    Cancer Res. 2019 Jul 23. pii: 0008-5472.CAN-19-0255.
    PubMed     Abstract available

  45. ZHANG H, Xing S, Li Z, Ma W, et al
    DIS3L2 promotes progression of hepatocellular carcinoma via hnRNP U-mediated alternative splicing.
    Cancer Res. 2019 Jul 22. pii: 0008-5472.CAN-19-0376.
    PubMed     Abstract available

  46. YOON AR, Hong J, Li Y, Shin HC, et al
    Mesenchymal stem cell-mediated delivery of an oncolytic adenovirus enhances antitumor efficacy in hepatocellular carcinoma.
    Cancer Res. 2019 Jul 9. pii: 0008-5472.CAN-18-3900.
    PubMed     Abstract available

  47. YE YC, Zhao JL, Lu YT, Gao CC, et al
    Notch signaling via Wnt regulates the proliferation of alternative, CCR2-independent tumor-associated macrophages in hepatocellular carcinoma.
    Cancer Res. 2019 Jul 2. pii: 0008-5472.CAN-18-1691.
    PubMed     Abstract available

    June 2019
  48. KAMAL Y, Schmit SL, Hoehn HJ, Amos CI, et al
    Transcriptomic differences between primary colorectal adenocarcinomas and distant metastases reveal metastatic colorectal cancer subtypes.
    Cancer Res. 2019 Jun 25. pii: 0008-5472.CAN-18-3945.
    PubMed     Abstract available

  49. WANG D, Fu L, Wei J, Xiong Y, et al
    PPARdelta mediates the effect of dietary fat in promoting colorectal cancer metastasis.
    Cancer Res. 2019 Jun 25. pii: 0008-5472.CAN-19-0384.
    PubMed     Abstract available

  50. WONG BS, Shea DJ, Mistriotis P, Tuntithavornwat S, et al
    A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic Cancer Cells.
    Cancer Res. 2019;79:2878-2891.
    PubMed     Abstract available

    May 2019
  51. LAN T, Yuan K, Yan X, Xu L, et al
    LncRNA SNHG10 facilitates hepatocarcinogenesis and metastasis by modulating its homolog SCARNA13 via a positive feedback loop.
    Cancer Res. 2019 May 17. pii: 0008-5472.CAN-18-4044.
    PubMed     Abstract available

  52. MALAKAR P, Stein I, Saragovi A, Winkler R, et al
    Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2.
    Cancer Res. 2019;79:2480-2493.
    PubMed     Abstract available

  53. GORDON JA, Noble JW, Midha A, Derakhshan F, et al
    Upregulation of Scavenger receptor B1 is required for steroidogenic and non-steroidogenic cholesterol metabolism in prostate cancer.
    Cancer Res. 2019 May 7. pii: 0008-5472.CAN-18-2529.
    PubMed     Abstract available

  54. ZHANG G, Li X, Chen Q, Li J, et al
    CD317 Activates EGFR by Regulating Its Association with Lipid Rafts.
    Cancer Res. 2019;79:2220-2231.
    PubMed     Abstract available

    March 2019
  55. SUN F, Wang Y, Luo X, Ma Z, et al
    Anti-CD24 antibody-nitric oxide conjugate (ANC) selectively and potently suppresses hepatic carcinoma.
    Cancer Res. 2019 Mar 27. pii: 0008-5472.CAN-18-2839.
    PubMed     Abstract available

  56. AMBROSINI G, Do C, Tycko B, Realubit RB, et al
    Inhibition of NF-kappaB-dependent signaling enhances sensitivity and overcomes resistance to BET inhibition in uveal melanoma.
    Cancer Res. 2019 Mar 18. pii: 0008-5472.CAN-18-3177.
    PubMed     Abstract available

  57. LILLO OSUNA MA, Garcia-Lopez J, El Ayachi I, Fatima I, et al
    Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis.
    Cancer Res. 2019;79:1054-1068.
    PubMed     Abstract available

  58. TAKAI A, Dang H, Oishi N, Khatib S, et al
    Genome-wide RNAi Screen identifies PMPCB as a therapeutic vulnerability in EpCAM+ hepatocellular carcinoma.
    Cancer Res. 2019 Mar 12. pii: 0008-5472.CAN-18-3015.
    PubMed     Abstract available

  59. FEKIR K, Dubois-Pot-Schneider H, Desert R, Daniel Y, et al
    Retrodifferentiation of human tumor hepatocytes to stem cells leads to metabolic reprogramming and chemoresistance.
    Cancer Res. 2019 Mar 5. pii: 0008-5472.CAN-18-2110.
    PubMed     Abstract available

    February 2019
  60. KWEE SA, Tiirikainen M, Sato MM, Acoba JD, et al
    Transcriptomics associates molecular features with 18F-fluorocholine PET/CT imaging phenotype and its potential relationship to survival in hepatocellular carcinoma.
    Cancer Res. 2019 Feb 13. pii: 0008-5472.CAN-18-3837.
    PubMed     Abstract available

  61. HAN J, Meng J, Wang X, Yin S, et al
    YY1 complex promotes Quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma.
    Cancer Res. 2019 Feb 13. pii: 0008-5472.CAN-18-2238.
    PubMed     Abstract available

  62. XU F, Li CH, Wong CH, Chen GG, et al
    Genome-wide screening and functional analysis identifies tumor suppressor long non-coding RNAs epigenetically silenced in hepatocellular carcinoma.
    Cancer Res. 2019 Feb 4. pii: 0008-5472.CAN-18-1659.
    PubMed     Abstract available

  63. OSHIMA G, Poli EC, Bolt MJ, Chlenski A, et al
    DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs.
    Cancer Res. 2019;79:650-662.
    PubMed     Abstract available

    December 2018
  64. CHEN SL, Zhang CZ, Liu LL, Lu SX, et al
    A GYS2/p53 negative feedback loop restricts tumor growth in HBV-related hepatocellular carcinoma.
    Cancer Res. 2018 Dec 24. pii: 0008-5472.CAN-18-2357.
    PubMed     Abstract available

  65. DONG Q, Du Y, Li H, Liu C, et al
    EGFR and c-MET cooperate to enhance resistance to PARP inhibitors in hepatocellular carcinoma.
    Cancer Res. 2018 Dec 20. pii: 0008-5472.CAN-18-1273.
    PubMed     Abstract available

  66. WOHLFEIL SA, Hafele V, Dietsch B, Schledzewski K, et al
    Hepatic endothelial Notch activation protects against liver metastasis by regulating endothelial-tumor cell adhesion independent of angiocrine signaling.
    Cancer Res. 2018 Dec 10. pii: 0008-5472.CAN-18-1752.
    PubMed     Abstract available

  67. GU Y, Wei X, Sun Y, Gao H, et al
    miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features.
    Cancer Res. 2018 Dec 7. pii: 0008-5472.CAN-18-1675.
    PubMed     Abstract available

    November 2018
  68. PENG L, Jiang B, Yuan X, Qiu Y, et al
    Super-enhancer-associated long non-coding RNA HCCL5 is activated by ZEB1 and promotes the malignancy of hepatocellular carcinoma.
    Cancer Res. 2018 Nov 27. pii: 0008-5472.CAN-18-0367.
    PubMed     Abstract available

    October 2018

  69. Correction: Telomerase-dependent Virotherapy Overcomes Resistance of Hepatocellular Carcinomas against Chemotherapy and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand by Elimination of Mcl-1.
    Cancer Res. 2018;78:6026.

    September 2018
  70. LIANG J, Chen M, Hughes D, Chumanevich AA, et al
    CDK8 selectively promotes the growth of colon cancer metastases in the liver by regulating gene expression of TIMP3 and matrix metalloproteinases.
    Cancer Res. 2018 Sep 5. pii: 0008-5472.CAN-18-1583.
    PubMed     Abstract available

  71. ROBERTSON CL, Mendoza RG, Jariwala N, Dozmorov M, et al
    Astrocyte elevated gene-1 (AEG-1) regulates macrophage activation in hepatocellular carcinogenesis.
    Cancer Res. 2018 Sep 4. pii: 0008-5472.CAN-18-0659.
    PubMed     Abstract available

    August 2018
  72. GU L, Zhu Y, Lin X, Li Y, et al
    Amplification of glyceronephosphate O-acyltransferase and recruitment of USP30 stabilize DRP1 to promote hepatocarcinogenesis.
    Cancer Res. 2018 Aug 24. pii: 0008-5472.CAN-18-0340.
    PubMed     Abstract available

    July 2018
  73. YAO Y, Sun S, Wang J, Fei F, et al
    Canonical Wnt signaling remodels lipid metabolism in zebrafish hepatocytes following Ras oncogenic insult.
    Cancer Res. 2018 Jul 31. pii: 0008-5472.CAN-17-3964.
    PubMed     Abstract available

  74. MAKINO Y, Hikita H, Kodama T, Shigekawa M, et al
    CTGF mediates tumor-stroma interactions between hepatoma cells and hepatic stellate cells to accelerate HCC progression.
    Cancer Res. 2018 Jul 2. pii: 0008-5472.CAN-17-3844.
    PubMed     Abstract available

  75. LI Y, Lin S, Li L, Tang Z, et al
    PDSS2 deficiency induces hepatocarcinogenesis by decreasing mitochondrial respiration and reprogramming glucose metabolism.
    Cancer Res. 2018 Jul 2. pii: 0008-5472.CAN-17-2172.
    PubMed     Abstract available

    June 2018
  76. QI LN, Xiang BD, Wu FX, Ye JZ, et al
    Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma.
    Cancer Res. 2018 Jun 18. pii: 0008-5472.CAN-17-2459.
    PubMed     Abstract available

  77. Retraction: Identification of Brain-Derived Neurotrophic Factor as a Novel Functional Protein in Hepatocellular Carcinoma.
    Cancer Res. 2018;78:3400.

  78. Retraction: The Potential Role of Hypoxia Inducible Factor 1alpha in Tumor Progression after Hypoxia and Chemotherapy in Hepatocellular Carcinoma.
    Cancer Res. 2018;78:3399.

  79. HILL MA, Alexander WB, Guo B, Kato Y, et al
    Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocarcinoma.
    Cancer Res. 2018 Jun 5. pii: 0008-5472.CAN-17-1123.
    PubMed     Abstract available

    May 2018
  80. MENG J, Chen S, Han J, Qian B, et al
    Twist1 regulates Vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma.
    Cancer Res. 2018 May 29. pii: 0008-5472.CAN-17-3009.
    PubMed     Abstract available

  81. WEN LZ, Ding K, Wang ZR, Ding CH, et al
    SHP-1 acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
    Cancer Res. 2018 May 18. pii: 0008-5472.CAN-17-3896.
    PubMed     Abstract available

    March 2018
  82. XU J, Yang Y, Xie R, Liu J, et al
    The NCX1/TRPC6 complex mediates TGFbeta-driven migration and invasion of human hepatocellular carcinoma cells.
    Cancer Res. 2018 Mar 2. pii: 0008-5472.CAN-17-2061.
    PubMed     Abstract available

  83. SAKAI E, Nakayama M, Oshima H, Kouyama Y, et al
    Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer.
    Cancer Res. 2018;78:1334-1346.
    PubMed     Abstract available

  84. VERZELLA D, Bennett J, Fischietti M, Thotakura AK, et al
    GADD45beta Loss Ablates Innate Immunosuppression in Cancer.
    Cancer Res. 2018;78:1275-1292.
    PubMed     Abstract available

    February 2018
  85. CAI Z, Qian ZY, Jiang H, Ma N, et al
    hPCL3s promotes hepatocellular carcinoma metastasis by activating beta-catenin signaling.
    Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-0028.
    PubMed     Abstract available

  86. CHENG BY, Lau EY, Leung HW, Leung CO, et al
    IRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma.
    Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-2445.
    PubMed     Abstract available

  87. LIU C, Liu L, Chen X, Cheng J, et al
    LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem-like Cells.
    Cancer Res. 2018;78:938-949.
    PubMed     Abstract available

  88. ZHANG YL, Li Q, Yang XM, Fang F, et al
    SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.
    Cancer Res. 2018 Feb 13. pii: 0008-5472.CAN-17-2867.
    PubMed     Abstract available

  89. KOHLI S, Bhardwaj A, Kumari R, Das S, et al
    SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
    Cancer Res. 2018;78:645-658.
    PubMed     Abstract available

    January 2018
  90. RHEE H, Kim HY, Choi JH, Woo HG, et al
    Keratin 19 expression in hepatocellular carcinoma is regulated by fibroblast-derived HGF via a MET-ERK1/2-AP1 and SP1 axis.
    Cancer Res. 2018 Jan 23. pii: 0008-5472.CAN-17-0988.
    PubMed     Abstract available

  91. SHEN J, Li P, Shao X, Yang Y, et al
    The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival.
    Cancer Res. 2018;78:359-371.
    PubMed     Abstract available

    December 2017
  92. JOSHI JJ, Coffey H, Corcoran E, Tsai J, et al
    H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma.
    Cancer Res. 2017;77:6999-7013.
    PubMed     Abstract available

    November 2017
  93. YAN Q, Jiang L, Liu M, Yu D, et al
    ANGPTL1 Interacts with Integrin alpha1beta1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.
    Cancer Res. 2017;77:5831-5845.
    PubMed     Abstract available

  94. D'COSTA Z, Jones K, Azad A, van Stiphout R, et al
    Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer.
    Cancer Res. 2017;77:5952-5962.
    PubMed     Abstract available

    October 2017
  95. ZHANG CZ, Chen SL, Wang CH, He YF, et al
    CBX8 exhibits oncogenic activity via AKT/beta-Catenin activation in hepatocellular carcinoma.
    Cancer Res. 2017 Oct 24. pii: canres.0700.2017.
    PubMed     Abstract available

  96. TSCHIDA BR, Temiz NA, Kuka TP, Lee LA, et al
    Sleeping Beauty insertional mutagenesis in mice identifies drivers of steatosis-associated hepatic tumor.
    Cancer Res. 2017 Oct 9. pii: canres.2281.2017.
    PubMed     Abstract available

    September 2017
  97. MATSUMOTO T, Takai A, Eso Y, Kinoshita K, et al
    Proliferating EpCAM-positive ductal cells in the inflamed liver give rise to hepatocellular carcinoma.
    Cancer Res. 2017 Sep 26. pii: canres.1800.2017.
    PubMed     Abstract available

  98. TENG Y, Zhao H, Gao L, Zhang W, et al
    FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4-GSK3beta-Nrf2 signaling.
    Cancer Res. 2017 Sep 26. pii: canres.2039.2017.
    PubMed     Abstract available

  99. YAN X, Zhang D, Wu W, Wu S, et al
    Mesenchymal stem cells promote hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and miR-34a.
    Cancer Res. 2017 Sep 25. pii: canres.1915.2017.
    PubMed     Abstract available

    August 2017
  100. MENDEZ-LUCAS A, Li X, Hu J, Che L, et al
    Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.
    Cancer Res. 2017;77:4355-4364.
    PubMed     Abstract available

  101. YE J, Li TS, Xu G, Zhao YM, et al
    JCAD Promotes Progression of Non-alcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.
    Cancer Res. 2017 Aug 3. pii: canres.0229.2017.
    PubMed     Abstract available

  102. WANG LT, Chiou SS, Chai CY, Hsi E, et al
    Intestine-Specific Homeobox Gene ISX Integrates IL6 Signaling, Tryptophan Catabolism, and Immune Suppression.
    Cancer Res. 2017;77:4065-4077.
    PubMed     Abstract available

    July 2017
  103. TILL J, Yoon C, Kim BJ, Roby KC, et al
    Oncogenic KRAS and p53 loss drive gastric tumorigenesis in mice that can be attenuated by E-cadherin expression.
    Cancer Res. 2017 Jul 31. pii: canres.0061.2017.
    PubMed     Abstract available

  104. NG KY, Chan LH, Chai S, Tong M, et al
    TP53INP1 down-regulation activates a p73-dependent DUSP10/ERK signaling pathway to promote metastasis of hepatocellular carcinoma.
    Cancer Res. 2017 Jul 3. pii: canres.3456.2016.
    PubMed     Abstract available

  105. BARBAZAN J, Alonso-Alconada L, Elkhatib N, Geraldo S, et al
    Liver Metastasis Is Facilitated by the Adherence of Circulating Tumor Cells to Vascular Fibronectin Deposits.
    Cancer Res. 2017;77:3431-3441.
    PubMed     Abstract available

    June 2017
  106. NGO HKC, Kim DH, Cha YN, Na HK, et al
    Nrf2 mutagenic activation drives hepatocarcinogenesis.
    Cancer Res. 2017 Jun 27. pii: canres.3538.2016.
    PubMed     Abstract available

  107. AKIEL M, Guo C, Li X, Rajasekaran D, et al
    IGFBP7 Deletion Promotes Hepatocellular Carcinoma.
    Cancer Res. 2017 Jun 15. pii: canres.2885.2016.
    PubMed     Abstract available

    April 2017
  108. WANG D, Sun H, Wei J, Cen B, et al
    CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 28. pii: canres.3199.2016.
    PubMed     Abstract available

  109. JARIWALA N, Rajasekaran D, Mendoza RG, Shen XN, et al
    Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.
    Cancer Res. 2017 Apr 20. pii: canres.0298.2017.
    PubMed     Abstract available

  110. YUE F, Li W, Zou J, Jiang X, et al
    Spermidine prolongs lifespan and prevents liver fibrosis and hepatocellular carcinoma by activating MAP1S-mediated autophagy.
    Cancer Res. 2017 Apr 6. pii: canres.3462.2016.
    PubMed     Abstract available

    March 2017
  111. QIAO G, Qin J, Kunda N, Calata J, et al
    LIGHT elevation enhances immune eradication of colon cancer metastases.
    Cancer Res. 2017 Mar 1. pii: canres.1655.2016.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.